相关实验视频

Updated: Jan 6, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

癌症转移:治疗挑战和机会

Sri Sathya Sandilya Garemilla¹, Manisha Choudhary Kadambala², Siri Chandana Gampa^2,3

¹School of Medicine and Health Sciences, The George Washington University, Ross Hall, 2300 Eye Street, Washington, D.C., NW, 20037, USA.

Medical oncology (Northwood, London, England)

|October 16, 2025

概括

转移性癌症是死亡的主要原因,正在重新定义. 了解瘤生物学和新的诊断/治疗方法的进步为管理这种疾病提供了希望.

科学领域:

在瘤学瘤学.
癌症生物学癌症生物学
翻译医学是一种翻译医学.

背景情况:

转移性癌症占全球90%的癌症死亡人数.
转移包括复杂的步骤:入侵,血管传播,循环生存和器官殖民.
瘤异质性,化学抵抗性和瘤微环境是关键的生物学挑战.

研究的目的:

审查了解转移性癌症生物学方面的最新进展.
检查新兴的转移的诊断和治疗策略.
突出个性化和适应性护理在转移性疾病管理中的潜力.

主要方法:

关于转移的当前文献的综述.
分析新兴的诊断工具 (例如液体活检,有机体).
检查新的治疗策略 (例如,向疗法,免疫疗法,纳米医学,AI).

主要成果:

向治疗 (BRAF/MEK 抑制剂) 可以改善黑色素瘤的无进展生存率.
免疫疗法 (PD-1/CTLA-4抑制剂) 在黑色素瘤和细胞癌中显示出高响应率.
液体活检,纳米医学,有机体和人工智能分析正在增强诊断和治疗个性化.

结论:

将先进的工具和疗法整合到临床试验中至关重要.
需要生物标志物驱动的选择,多中心验证和监管框架.
这些进展使转移性癌症通过个性化,适应性护理转变为可管理的疾病.

关键词:

人工智能的人工智能是人工智能.生物标志物生物标志物癌症免疫疗法癌症免疫疗法化学抗药性化学抗药性是一种抗药性.液体活检液体活检转移转移转移转移精确瘤学是一门精确的专业.有针对性的治疗.瘤异质性瘤异质性瘤微环境是一个微环境.

更多相关视频

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

In Vivo Imaging to Measure Spontaneous Lung Metastasis of Orthotopically-injected Breast Tumor Cells

In Vivo Imaging to Measure Spontaneous Lung Metastasis of Orthotopically-injected Breast Tumor Cells

Published on: June 23, 2022

相关概念视频

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...